Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma

International Journal of Oncology

Volumn 32, Issue 6, 2008, Pages 1253-1261

  Sogabe, Yohei ^a,b   Suzuki, Hiromu ^b   Toyota, Minoru ^a,b   Ogi, Kazuhiro ^b   Imai, Takashi ^b   Nojima, Masanori ^b   Sasaki, Yasushi ^a   Hiratsuka, Hiroyoshi ^b   Tokino, Takashi ^a  

^a Department of Molecular Biology   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

catenin; Methylation; Oral squamous cell carcinoma; Secreted frizzled related protein; Wnt

Indexed keywords

BETA CATENIN; GLYCOPROTEIN; MEMBRANE PROTEIN; SECRETED FRIZZLED RELATED PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 5; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; APC PROTEIN; CADHERIN; CDH1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; EYE PROTEIN; SFRP1 PROTEIN, HUMAN; SFRP2 PROTEIN, HUMAN; SFRP5 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METHYLATION; MOUTH CANCER; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; DNA METHYLATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; MUTATION; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOMATOUS POLYPOSIS COLI PROTEIN; AGED; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; EYE PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; WNT PROTEINS;

EID: 48149091803     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_32_6_1253     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Gangane N, Chawla S, Subodh A, Gupta S and Sharma SM: Reassessment of risk factors for oral cancer. Asian Pac J Cancer Prev 8: 243-248, 2007.
3. Petti S and Scully C: Oral cancer: the association between nation-based alcohol-drinking profiles and oral cancer mortality. Oral Oncol 41: 828-834, 2005.
4. Chiba I, Shindoh M, Yasuda M, et al: Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 12: 1663-1668, 1996.
5. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM and Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 1152-1155, 1994.
6. Partridge M, Emilion G, Pateromichelakis S, Phillips E and Langdon J: Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer 83: 318-325, 1999.
7. Ha PK and Califano JA: Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 7: 77-82, 2006.
8. Ogi K, Toyota M, Ohe-Toyota M, et al: Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma, Clin Cancer Res 8: 3164-3171, 2002.
9. Nakayama S, Sasaki A, Mese H, et al: The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int J Cancer 93: 667-673, 2001.
10. Ogi K, Toyota M, Mita H, Satoh A, Kashima L, Sasaki Y, Suzuki H, Akino K, Nishikawa N, Noguchi M, Shinomura Y, Imai K, Hiratsuka H and Tokino T: Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors. Cancer Biol Ther 4: 773-780, 2005.
11. Shaw RJ, Liloglou T, Rogers SN, et al: Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94: 561-568, 2006.
12. Tran TN, Liu Y, Takagi M, Yamaguchi A and Fujii H: Frequent promoter hypermethylation of RASSF1A and pl6INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population. J Oral Pathol Med 34: 150-156, 2005.
13. Cadigan KM and Nusse R: Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305, 1997.
14. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
15. Moon RT, Kohn AD, De Ferrari GV and Kaykas A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701, 2004.
16. Largey JS, Meltzer SJ, Sank JJ, Hebert CA and Archibald DW: Loss of heterozygosity involving the APC gene in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol 77: 260-263, 1994.
17. Uzawa K, Yoshikawa H, Suzuki H, Tanzawa H, Shimazaki J, Seino S and Sato K: Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma. Int J Cancer 58: 814-817, 1994.
18. Huang JS, Chiang CP, Kok SH, Kuo YS and Kuo MYP: Loss of heterozygosity APC and MCC genes in oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 26: 322-326, 1997.
19. Chang KW, Lin SC, Marigold KA, Jean MS, Yuan TC, Lin SN and Chang CS: Alteration of adenomatous polyposis coli(APC) gene in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 29: 223-226, 2000.
20. Gao S, Eiberg H, Krogdahl A, Liu CJ and Sorensen JA: Cytoplasmic expression of E-cadherin and beta-Catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas. J Oral Pathol Med 34: 116-119, 2005.
21. Yeh KT, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC and Lin CC: Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. Int J Oncol 23: 1001-1007, 2003,
22. Iwai S, Katagiri W, Kong C, Amekawa S, Nakazawa M and Yura Y: Mutation of the APC, beta-catenin, and axin1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol 131: 773-782, 2005.
23. Williams HK, Sanders DSA, Jankowski JAZ, Landini G and Brown AMS: Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J oral Pathol Med 27: 308-317, 1998.
24. Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, Testa NF and De Rosa G: Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 19: 3817-3826, 1999.
25. Ueda G, Sunakawa H, Nakamori K, Shinya T, Tsuhako W, Tamura Y, Kosugi T, Sato N, Ogi K and Hiratsuka H: Aberrant expression of β- and γ-catenin is an independent prognostic marker in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 35: 356-361, 2006.
26. Kawano Y and Kypta R: Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627-2634, 2003.
27. Jones SE and Jomary C: Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays 24: 811-820, 2002.
28. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG and Baylin SB: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141-149, 2002.
29. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG and Baylin SB: Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36: 417-422, 2004.
30. Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, Hirata K, Itoh F, Tokino T, Mori M, Imai K and Shinomura Y: Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 26: 4699-4713, 2007.
31. Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C and Hartmann A: Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest 84: 465-478, 2004.
32. Lodygin D, Epanchintsev A, Menssen A, Diebold J and Hermeking H: Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65: 4218-4227, 2005.
33. Fukui T, Kondo M, Ito G, Maeda O, Sato N, Yoshioka H, Yokoi K, Ueda Y, Shimokata K and Sekido Y: Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 24: 6323-6327, 2005.
34. Lo PK, Mehrotra J, D'Costa A, Fackler MJ, Garrett-Mayer E, Argani P and Sukumar S: Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther 5: 281-286, 2006.
35. Liu TH, Raval A, Chen SS, Matkovic JJ, Byrd JC and Plass C: CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res 66: 653-658, 2006.
36. Kanaseki T, Ikeda H, Takamura Y, Toyota M, Hirohashi Y, Tokino T, Himi T and Sato N: Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas. J Immunol 170: 4980-4985, 2003.
37. Sasaki Y, Morimoto I, Kusano M, Hosokawa M, Itoh F, Yanagihara K, Imai K and Tokino T: Mutational analysis of the beta-catenin gene in gastric carcinomas. Tumour Biol 22: 123-130, 2001.
38. Esteller M: Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298, 2007.
39. Chang HW, Chow V, Lam KY, Wei WI and Yuen A: Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 94: 386-392, 2002.